Francisco Miqueles
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Francisco Miqueles has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Adrian G. Palacios
Centro Interdisciplinario de Neurociencia de Valparaíso, Universidad de Valparaíso, Valparaíso, Chile
1 shared publication - Bruno Cerda
Pontificia Universidad Católica de Chile
1 shared publication - Claudia Duran-Aniotz
Latin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago de Chile, Chile
1 shared publication - Claudio Hetz
Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, University of Chile, Santiago, Chile
1 shared publication - Cristobal Rojas
Pontificia Universidad Católica de Chile
1 shared publication - Daniela Ponce
Universidad de Valparaíso
1 shared publication
Latest Publications
- Open Access
XBP1s as a Therapeutic Target to Preserve Retinal Function During Aging and Neurodegeneration
Loss of physiological complexity, characterized by reduced adaptive multiscale coordination among system components, is increasingly recognized as a hallmark of aging and neurodegenerative disease. The retina, a window into the brain, offers a unique, accessible platform to monitor neurodegenerative disorders such as Alzheimer’s disease (AD). Here, we investigate the therapeutic potential of the unfolded protein response transcription factor XBP1s in preserving retinal function during aging and AD-related pathology in murine models. Using micro-electroretinography with multielectrode arrays, we recorded retinal responses to chirp and white noise stimuli in four mouse models: wild-type (WT), XBP1s-overexpressing (Tg XBP1s ), AD model (5xFAD), and their crossbreed (Tg XBP1s /5xFAD) at approximately 3 and 7 months of age. We assessed retinal signals through entropy-based complexity measures and wavelet coherence between stimulus and response. While WT and 5xFAD mice exhibited age-related decline in retinal complexity, Tg XBP1s and Tg XBP1s /5xFAD mice maintained higher complexity levels and increased Wcoh in adulthood, indicating functional preservation. These results demonstrate that sus-tained XBP1s expression protects retinal electrophysiological integrity and highlight the retina’s value as a scalable, noninvasive biomarker platform to evaluate therapeutic efficacy targeting neurodegenerative mechanisms.
Open AccessXBP1s as a Therapeutic Target to Preserve Retinal Function During Aging and Neurodegeneration
Loss of physiological complexity, characterized by reduced adaptive multiscale coordination among system components, is increasingly recognized as a hallmark of aging and neurodegenerative disease. The retina, a window into the brain, offers a unique, accessible platform to monitor neurodegenerative disorders such as Alzheimer’s disease (AD). Here, we investigate the therapeutic potential of the unfolded protein response transcription factor XBP1s in preserving retinal function during aging and AD-related pathology in murine models. Using micro-electroretinography with multielectrode arrays, we recorded retinal responses to chirp and white noise stimuli in four mouse models: wild-type (WT), XBP1s-overexpressing (Tg XBP1s ), AD model (5xFAD), and their crossbreed (Tg XBP1s /5xFAD) at approximately 3 and 7 months of age. We assessed retinal signals through entropy-based complexity measures and wavelet coherence between stimulus and response. While WT and 5xFAD mice exhibited age-related decline in retinal complexity, Tg XBP1s and Tg XBP1s /5xFAD mice maintained higher complexity levels and increased Wcoh in adulthood, indicating functional preservation. These results demonstrate that sus-tained XBP1s expression protects retinal electrophysiological integrity and highlight the retina’s value as a scalable, noninvasive biomarker platform to evaluate therapeutic efficacy targeting neurodegenerative mechanisms.